Finance

Lists
LUPIN:NSE
Lupin Ltd
1 953,20 INR
-0,02%
(-0,40) 1D
14 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LUPIN...
Open
1 950,00 INR
High
1 954,80 INR
Low
1 925,70 INR
Mkt. cap
892,43 მლრ.
Avg. vol.
713,74 ათ.
Volume
795,62 ათ.
Dividend
0,92%
Quarterly dividend
4,50 INR
Ex-dividend date
17 ივლ. 2026
P/E ratio
15,27
52-wk high
2 529,50 INR
52-wk low
1 900,00 INR
EPS
127,94 INR
Shares outstanding
452,41 მლნ.
No. of employees
26 ათ.
Open
1 950,00 INR
High
1 954,80 INR
Low
1 925,70 INR
Mkt. cap
892,43 მლრ.
Avg. vol.
713,74 ათ.
Volume
795,62 ათ.
Dividend
0,92%
Quarterly dividend
4,50 INR
Ex-dividend date
17 ივლ. 2026
P/E ratio
15,27
52-wk high
2 529,50 INR
52-wk low
1 900,00 INR
EPS
127,94 INR
Shares outstanding
452,41 მლნ.
No. of employees
26 ათ.
News stories
From web sources and news partners
Profile
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia.. Wikipedia
About Lupin Ltd
CEOვინიტა დი გუფტა
Employees26 ათ.
Founded1968
Headquartersმუმბაი, მაჰარაშტრა, ინდოეთი
SectorPharmaceutical industry
Websitelupin.com
Last report
7 აგვ. 2026
Fiscal period
Q1 2027
30,89 INR / 28,89 INR
+6,93%beat
Revenue / Est. (INR)
82,77 მლრდ. / 79,18 მლრდ.
+4,53%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
70,48 მლრდ.
71,68 მლრდ.
74,75 მლრდ.
82,77 მლრდ.
Cost of goods sold
18,25 მლრდ.
18,78 მლრდ.
24,90 მლრდ.
20,89 მლრდ.
Cost of revenue
18,25 მლრდ.
18,78 მლრდ.
24,90 მლრდ.
20,89 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,06 მლრდ.
11,43 მლრდ.
13,85 მლრდ.
13,83 მლრდ.
Operating expense
34,02 მლრდ.
33,93 მლრდ.
31,74 მლრდ.
40,89 მლრდ.
Total operating expenses
52,27 მლრდ.
52,71 მლრდ.
56,64 მლრდ.
61,78 მლრდ.
Operating income
18,21 მლრდ.
18,97 მლრდ.
18,10 მლრდ.
20,99 მლრდ.
Other non operating income
900,00 მლნ.
1,15 მლრდ.
-2,87 მლრდ.
1,30 მლრდ.
EBT including unusual items
20,07 მლრდ.
15,22 მლრდ.
19,28 მლრდ.
20,17 მლრდ.
EBT excluding unusual items
20,07 მლრდ.
19,49 მლრდ.
19,91 მლრდ.
21,05 მლრდ.
Income tax expense
5,22 მლრდ.
3,42 მლრდ.
4,59 მლრდ.
6,00 მლრდ.
Effective tax rate
26,02%
22,44%
23,82%
29,76%
Other operating expenses
19,80 მლრდ.
19,37 მლრდ.
14,55 მლრდ.
23,41 მლრდ.
Net income
14,78 მლრდ.
11,76 მლრდ.
14,60 მლრდ.
14,15 მლრდ.
Net profit margin
20,97%
16,40%
19,54%
17,10%
Earnings per share
32,28
32,18
34,75
30,89
Interest and investment income
-
-
2,17 მლრდ.
-
Interest expense
-1,08 მლრდ.
-1,15 მლრდ.
-633,10 მლნ.
-1,10 მლრდ.
Net interest expenses
-1,08 მლრდ.
-1,15 მლრდ.
1,54 მლრდ.
-1,10 მლრდ.
Depreciation and amortization charges
3,17 მლრდ.
3,13 მლრდ.
3,34 მლრდ.
3,65 მლრდ.
EBITDA
21,29 მლრდ.
21,20 მლრდ.
20,81 მლრდ.
23,69 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები